| Primary |
| Hiv Infection |
74.0% |
| Antiretroviral Therapy |
7.8% |
| Anxiety |
5.0% |
| Back Pain |
4.9% |
| Hepatitis C |
1.3% |
| Hypertension |
0.7% |
| Headache |
0.6% |
| Hiv Test Positive |
0.6% |
| Acquired Immunodeficiency Syndrome |
0.5% |
| Hyperchlorhydria |
0.5% |
| Supplementation Therapy |
0.5% |
| Depression |
0.4% |
| Eczema |
0.4% |
| Infection |
0.4% |
| Arthralgia |
0.4% |
| Hepatitis B |
0.4% |
| Hypercholesterolaemia |
0.4% |
| Prophylaxis |
0.4% |
| Psychotic Disorder |
0.4% |
| Drug Exposure During Pregnancy |
0.3% |
|
| Pregnancy |
31.4% |
| Nephrolithiasis |
9.7% |
| Renal Failure Acute |
5.3% |
| Hyperbilirubinaemia |
4.9% |
| Pneumonia |
4.9% |
| Renal Failure |
4.4% |
| Blood Alkaline Phosphatase Increased |
4.0% |
| Renal Colic |
4.0% |
| Rhabdomyolysis |
4.0% |
| Abortion Spontaneous |
3.5% |
| Myositis |
3.5% |
| Drug Interaction |
3.1% |
| Small For Dates Baby |
3.1% |
| Arrhythmia |
2.7% |
| Jaundice |
2.7% |
| Acute Hiv Infection |
1.8% |
| Basedow's Disease |
1.8% |
| Haemolytic Anaemia |
1.8% |
| Premature Labour |
1.8% |
| Sepsis |
1.8% |
|
| Secondary |
| Hiv Infection |
63.7% |
| Product Used For Unknown Indication |
8.9% |
| Drug Use For Unknown Indication |
6.8% |
| Antiretroviral Therapy |
4.0% |
| Drug Exposure During Pregnancy |
3.0% |
| Hepatitis C |
2.4% |
| Acquired Immunodeficiency Syndrome |
1.8% |
| Hypertension |
1.4% |
| Maternal Exposure Timing Unspecified |
1.0% |
| Prophylaxis |
0.9% |
| Antifungal Prophylaxis |
0.8% |
| Mycobacterium Avium Complex Infection |
0.8% |
| Insomnia |
0.7% |
| Tuberculosis |
0.7% |
| Factor Viii Deficiency |
0.6% |
| Depression |
0.6% |
| Maternal Exposure During Pregnancy |
0.6% |
| Hiv Test Positive |
0.5% |
| Antibiotic Prophylaxis |
0.5% |
| Hypercholesterolaemia |
0.5% |
|
| Thrombocytopenia |
8.9% |
| Foetal Exposure During Pregnancy |
6.4% |
| Parkinsonism |
6.4% |
| Vomiting |
6.4% |
| Renal Failure Acute |
5.9% |
| Stillbirth |
5.9% |
| Weight Decreased |
5.9% |
| Abortion Spontaneous |
4.9% |
| Hyperbilirubinaemia |
4.9% |
| Renal Failure |
4.9% |
| Rhabdomyolysis |
4.9% |
| Drug Interaction |
4.4% |
| Liver Injury |
4.4% |
| Rash |
4.4% |
| White Blood Cell Count Decreased |
3.9% |
| Immune Reconstitution Syndrome |
3.4% |
| Maternal Exposure During Pregnancy |
3.4% |
| Nausea |
3.4% |
| Pain In Extremity |
3.4% |
| Portal Hypertension |
3.4% |
|
| Concomitant |
| Hiv Infection |
62.0% |
| Product Used For Unknown Indication |
13.7% |
| Drug Use For Unknown Indication |
5.7% |
| Hepatitis C |
5.0% |
| Antiretroviral Therapy |
2.9% |
| Hypertension |
1.2% |
| Acquired Immunodeficiency Syndrome |
1.0% |
| Depression |
0.9% |
| Drug Exposure During Pregnancy |
0.9% |
| Antibiotic Prophylaxis |
0.8% |
| Drug Hypersensitivity |
0.8% |
| Prophylaxis |
0.7% |
| Pain |
0.7% |
| Antifungal Prophylaxis |
0.7% |
| Cough |
0.7% |
| Hiv Test Positive |
0.6% |
| Bronchitis Chronic |
0.4% |
| End Stage Aids |
0.4% |
| Prophylaxis Against Hiv Infection |
0.4% |
| Influenza Like Illness |
0.4% |
|
| Rash |
8.9% |
| Renal Failure Acute |
7.6% |
| Vomiting |
7.6% |
| Weight Decreased |
6.8% |
| Transaminases Increased |
6.4% |
| Ventricular Septal Defect |
5.9% |
| Blood Alkaline Phosphatase Increased |
5.5% |
| Pneumonia |
5.5% |
| Ultrasound Antenatal Screen Abnormal |
4.7% |
| Abortion Spontaneous |
4.2% |
| Blood Bilirubin Unconjugated Increased |
4.2% |
| Thrombocytopenia |
4.2% |
| Hyperbilirubinaemia |
3.8% |
| Myocardial Infarction |
3.8% |
| Osteonecrosis |
3.8% |
| Rhabdomyolysis |
3.8% |
| Drug Interaction |
3.4% |
| Overdose |
3.4% |
| Pyrexia |
3.4% |
| Renal Failure |
3.0% |
|
| Interacting |
| Hiv Infection |
40.7% |
| Antiretroviral Therapy |
20.8% |
| Product Used For Unknown Indication |
8.8% |
| Gastrooesophageal Reflux Disease |
5.3% |
| Pulmonary Hypertension |
2.7% |
| Anxiety Disorder |
2.2% |
| Drug Use For Unknown Indication |
2.2% |
| Bipolar Disorder |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Acquired Immunodeficiency Syndrome |
1.3% |
| Anxiety |
1.3% |
| Colitis |
1.3% |
| Cytomegalovirus Chorioretinitis |
1.3% |
| Increased Appetite |
1.3% |
| Nausea |
1.3% |
| Neutropenia |
1.3% |
| Prophylaxis |
1.3% |
| Renal Transplant |
1.3% |
| Hepatic Neoplasm Malignant |
0.9% |
| Hepatitis B |
0.9% |
|
| Cushing's Syndrome |
14.3% |
| Drug Level Increased |
11.4% |
| Drug Interaction |
8.6% |
| Renal Tubular Necrosis |
8.6% |
| Drug Level Decreased |
5.7% |
| Haemolytic Anaemia |
5.7% |
| Overdose |
5.7% |
| Sedation |
5.7% |
| Adrenal Suppression |
2.9% |
| Alanine Aminotransferase Increased |
2.9% |
| Aspartate Aminotransferase Increased |
2.9% |
| Blood Ph Decreased |
2.9% |
| Embolism Venous |
2.9% |
| Herpes Simplex |
2.9% |
| Hyperlipidaemia |
2.9% |
| Hypotension |
2.9% |
| Lipids Increased |
2.9% |
| Nephrolithiasis |
2.9% |
| Priapism |
2.9% |
| Renal Tubular Disorder |
2.9% |
|
